专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

KR1020100043721A 혈압 강하용 약학 조성물 无效
标题翻译：用于降低血液水平的药物组合物
公开(公告)号：KR1020100043721A
公开(公告)日：2010-04-29
申请号：KR1020080102894
申请日：2008-10-21
申请人： 현대약품 주식회사
发明人： 이규현 , 박홍준 , 신창용 , 명창선
IPC分类号： A61K31/4184 , A61K31/44 , A61P9/12
CPC分类号： A61K31/4184 , A61K31/4422 , A61K2300/00
摘要： PURPOSE: A pharmaceutical composition for reducing blood pressure through synergic effect of termisartan and lercanidipine is provided. CONSTITUTION: A pharmaceutical composition for reducing blood pressure contains effective amount of telmisartan and lercanidipine. The pharmaceutical composition contains 5-80 mg of telmisartan and 1.25-20 mg of lercanidipine in a weight ratio of 64 : 1-1 : 4. The pharmaceutical composition is manufactured in the form of oral formulation. The pharmaceutical composition is used for preventing or treating hypertension, cardiac insufficiency, arteria coronaria atresia choanae, ischemic heart disease, ischemic peripheral circulatory system disease, hypertensive renal failure, stroke or artery scleroma.
摘要翻译：目的：提供一种药物组合物，通过协同效应降低血压，因此可用于替拉西定。构成：用于降低血压的药物组合物含有有效量的替米沙坦和氯卡地平。药物组合物含有5-80mg替米沙坦和1.25-20mg重量比为64:1-1:4的氯卡地平。药物组合物以口服制剂的形式制备。药物组合物用于预防或治疗高血压，心功能不全，冠状动脉闭塞性闭锁，缺血性心脏病，缺血性外周循环系统疾病，高血压性肾衰竭，中风或动脉硬化。

2. 发明公开

KR1020100046923A 약학 조성물 无效
标题翻译：药物组合物
公开(公告)号：KR1020100046923A
公开(公告)日：2010-05-07
申请号：KR1020080105967
申请日：2008-10-28
申请人： 현대약품 주식회사
发明人： 이규현 , 박홍준 , 신창용 , 명창선
IPC分类号： A61K31/403 , A61K31/5415 , A61P9/12
CPC分类号： A61K31/403 , A61K9/0053 , A61K31/41 , A61K31/4184 , A61K2300/00 , Y10S514/824
摘要： PURPOSE: A pharmaceutical composition containing ramipril and telmisartan or valsartan is provided to ensure effective blood pressure reduction and to suppress heart damage. CONSTITUTION: A pharmaceutical composition for reducing blood pressure contains effective amount of ramipril and telmisartan or valsartan as an active ingredient. A pharmaceutical composition contains 0.312-5 mg of ramipril and 10-160mg of valsartan. A pharmaceutical composition contains 0.312-5mg and 5-80 mg of telmisartan. The pharmaceutical composition is used in the oral formulation. The pharmaceutical composition is used in treating or preventing hypertension, cardiac insufficiency, arteria coronaria atresia choanae, ischemic heart disease, ischemic peripheral circulatory system disease, hypertensive renal failure, stroke or artery scleroma.
摘要翻译：目的：提供含有雷米普利和替米沙坦或缬沙坦的药物组合物，以确保有效降低血压并抑制心脏损伤。构成：用于降低血压的药物组合物含有有效量的雷米普利和替米沙坦或缬沙坦作为活性成分。药物组合物含有0.312-5mg的雷米普利和10-160mg的缬沙坦。药物组合物含有0.312-5mg和5-80mg替米沙坦。药物组合物用于口服制剂中。药物组合物用于治疗或预防高血压，心功能不全，冠状动脉闭塞性闭锁，缺血性心脏病，缺血性外周循环系统疾病，高血压性肾衰竭，中风或动脉硬化。

3. 发明公开

KR1020100048137A 혈압 강하용 약학 조성물 无效
标题翻译：抗高血糖药物组合物
公开(公告)号：KR1020100048137A
公开(公告)日：2010-05-11
申请号：KR1020080107163
申请日：2008-10-30
申请人： 현대약품 주식회사
发明人： 이규현 , 박홍준 , 신창용 , 명창선
IPC分类号： A61K31/4184 , A61P9/12
CPC分类号： A61K31/4184 , A61K9/0053 , A61K31/401 , A61K31/403 , A61K31/41 , A61K31/4178 , A61K31/4418 , A61K31/451 , A61K2300/00 , Y10S514/824
摘要： PURPOSE: A pharmaceutical composition for reducing blood pressure containing angiotensin II receptor blocker, angiotensin converting enzyme inhibitor, or calcium channel blocker is provided. CONSTITUTION: A pharmaceutical composition for reducing blood pressure contains an angiotensin II receptor blocker of candesartan, losartan, olmesartan, valsartan, irbesartan, or telmisartan; an angiotensin converting enzyme inhibitor of ramipril, lisinopril, or perindopril; and a calcium channel blocker of amlodipine, lacidipine, cilnidipine, or lercanidipine. The composition is used in preventing or treating hypertension, cardiac insufficiency, arteria coronaria atresia choanae, ischemic heart disease, ischemic peripheral circulatory system disease, hypertensive renal failure, stroke or artery scleroma.
摘要翻译：目的：提供一种用于降血压的血管紧张素II受体阻断剂，血管紧张素转换酶抑制剂或钙通道阻断剂的药物组合物。构成：用于降低血压的药物组合物含有坎地沙坦，氯沙坦，奥美沙坦，缬沙坦，厄贝沙坦或替米沙坦的血管紧张素II受体阻断剂; 雷米普利，赖诺普利或培哚普利的血管紧张素转换酶抑制剂; 和氨氯地平，拉西地平，西尼地平或氯卡地平钙通道阻滞剂。该组合物用于预防或治疗高血压，心功能不全，冠状动脉闭锁性闭锁，缺血性心脏病，缺血性外周循环系统疾病，高血压性肾衰竭，中风或动脉硬化。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式